VANFLYTA First FLT3 Inhibitor Approved in the U.S. Specifically for Patients with Newly Diagnosed FLT3-ITD Positive AML Read more
BioCryst Selects Er-Kim Pharmaceuticals as Commercial Partner for ORLADEYO (berotralstat) in Turkey Read more
Eleven Therapeutics Announces Research Collaboration with Novo Nordisk to Discover Cell-Specific Carriers of Nucleic Acid Therapeutics Read more
FDA Approves Veklury (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis Read more
European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Zolbetuximab Read more
Gilead Partners with CHAI and Penta to Improve Treatment and Adherence Rates Among Children with HIV in Low and Middle Income Countries Read more